2023 Annual Meeting | C170 - Inherited Neuropathies Update
01:00 PM - 01:05 PM EST | Introduction |
Introduction
Michael E. Shy, MD, FAAN |
01:05 PM - 01:35 PM EST | Speaker |
Inherited Neuropathies-Clinical Overview
Tyler A. Rehbein, MD |
01:35 PM - 02:10 PM EST | Speaker |
Evaluating Progression in Inherited Neuropathies; Clinical Outcomes and Biomarkers
Michael E. Shy, MD, FAAN |
02:10 PM - 02:45 PM EST | Speaker |
Genetic Diagnosis in Inherited Neuropathies
Stephan Zuchner, MD, FAAN |
02:45 PM - 03:00 PM EST | Discussion |
Questions and Answers
Michael E. Shy, MD, FAAN, Stephan Zuchner, MD, FAAN, Tyler A. Rehbein, MD |
Michael E. Shy, MD, FAAN | Dr. Shy has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Applied Therapeutics. The institution of Dr. Shy has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for DTx Pharma. The institution of Dr. Shy has received research support from NIH. The institution of Dr. Shy has received research support from Muscular Dystrophy Association. The institution of Dr. Shy has received research support from Charcot Marie Tooth Association. The institution of Dr. Shy has received research support from Applied Therapeutics. |
Stephan Zuchner, MD, FAAN | Dr. Zuchner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Applied Therapeutics. The institution of Dr. Zuchner has received research support from Muscular Dystrophy Association. The institution of Dr. Zuchner has received research support from CMT Association. Dr. Zuchner has received intellectual property interests from a discovery or technology relating to health care. |
Tyler A. Rehbein, MD | The institution of Dr. Rehbein has received research support from Neuromuscular Study Group, American Brain Foundation, and 好色先生. |